Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Buse leads clinical trial of new type 1 diabetes treatment
The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.
Located in News / 2017 / November
Diabetes drug lowers risk of cardiovascular complications, kidney disease
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.
Located in News / 2016 / June
Duke/UNC Team Testing New Strategies to Prevent Clotting in Patients with Pancreatic Cancer
CTSA collaborative funding award supports mouse-model research. Nigel Mackman, PhD, of UNC, and Rebekah White, MD, of Duke are leading the effort.
Located in News / 2016 / June
Gathering Big Data to Accelerate COVID-19 fight
Scientists around the country are creating a secure, central database of electronic health records from coronavirus patients to aid in the ongoing effort to treat patients effectively. The UNC-Chapel Hill site leader is John Buse, MD, PhD, director of the NC TraCS Institute.
Located in News / 2020 / May
Life-extending benefits of liver cancer drug not realistic for many patients
The drug sorafenib can have serious side effects and significant out-of-pocket costs for advanced liver cancer patients, according to a study led by UNC’s Hanna Sanoff, MD, MPH.
Located in News / 2016 / May
Liquid Metal ‘Nano-Terminators’ Target Cancer Cells
The new cancer drug delivery system improved efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.
Located in News / 2015 / December
Microneedle patch delivers localized cancer immunotherapy to melanoma
UNC / NC State researchers devise a new nanotechnology to enhance the body’s own immune response to kill skin cancer tumors.
Located in News / 2016 / March
NC TraCS and partners awarded $58.1 million to accelerate research discoveries
The NIH award features a new partnership with NC State, while the UNC-Chapel Hill-led Clinical and Translational Science Award Program continues its alliance with RTI International and N.C. A&T State University.
Located in News / 2018 / April
Scientists create painless patch of insulin-producing beta cells to control diabetes
The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.
Located in News / 2016 / March
Smart Artificial Beta Cells Could Lead to New Diabetes Treatment
In lab experiments and animal models, UNC and NC State researchers led by Zhen Gu, PhD, designed synthetic beta cells to secrete insulin in response to high blood sugar.
Located in News / 2017 / October